πŸ‡ΊπŸ‡Έ FDA
Patent

US 11414416

Compounds and uses thereof

granted A61PA61P35/00

Quick answer

US patent 11414416 (Compounds and uses thereof) held by FOGHORN THERAPEUTICS INC. expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
FOGHORN THERAPEUTICS INC.
Grant date
Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P35/00